Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E G Mansour

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Cancer|March 17, 2001
Comparison of 5-fluorouracil alone, 5-fluorouracil with levamisole, and 5-fluorouracil with hepatic irradiation in the treatment of patients with residual, nonmeasurable, intra-abdominal metastasis after undergoing resection for colorectal carcinomaR S Witte, A Cnaan, E G Mansour, et al.
Biochemical Pharmacology|November 15, 1985
Comparison of the membrane-related effects of cytarabine and other agents on model membranesK A Koehler, J Hines, E G Mansour, et al.
Surgery|October 1, 1985
The efficacy of polyethylene glycol-electrolyte lavage solution versus traditional mechanical bowel preparation for elective colonic surgery: a randomized, prospective, blinded clinical trialR A Fleites, J B Marshall, M L Eckhauser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 1998
Survival advantage of adjuvant chemotherapy in high-risk node-negative breast cancer: ten-year analysis--an intergroup studyE G Mansour, R Gray, A H Shatila, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1992
Chemotherapy versus observation in high-risk node-negative breast cancer patientsE G Mansour, L Eudey, D C Tormey, et al.
The New England Journal of Medicine|February 23, 1989
Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup studyE G Mansour, R Gray, A H Shatila, et al.
Cancer Treatment Reports|October 1, 1987
Actual versus ideal weight in the calculation of surface area: effects on dose of 11 chemotherapy agentsR S Gelman, D C Tormey, R Betensky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Concurrent radiation therapy and chemotherapy for locally unresectable squamous cell head and neck cancer: an Eastern Cooperative Oncology Group pilot studyD J Adelstein, L A Kalish, G L Adams, et al.
Blood|August 1, 1991
Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for relapsed non-Hodgkin's lymphoma: blood and bone marrow progenitor growth studies. A phase II Eastern Cooperative Oncology Group TrialH M Lazarus, J Andersen, M G Chen, et al.
American Journal of Clinical Oncology|August 1, 1995
Phase II trial of etoposide, doxorubicin, and cisplatin combination in advanced measurable gastric cancer. An Eastern Cooperative Oncology Group studyJ L Clark, O Küçük, D S Neuberg, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Cancer|March 17, 2001
Comparison of 5-fluorouracil alone, 5-fluorouracil with levamisole, and 5-fluorouracil with hepatic irradiation in the treatment of patients with residual, nonmeasurable, intra-abdominal metastasis after undergoing resection for colorectal carcinomaR S Witte, A Cnaan, E G Mansour, et al.
Biochemical Pharmacology|November 15, 1985
Comparison of the membrane-related effects of cytarabine and other agents on model membranesK A Koehler, J Hines, E G Mansour, et al.
Surgery|October 1, 1985
The efficacy of polyethylene glycol-electrolyte lavage solution versus traditional mechanical bowel preparation for elective colonic surgery: a randomized, prospective, blinded clinical trialR A Fleites, J B Marshall, M L Eckhauser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 1998
Survival advantage of adjuvant chemotherapy in high-risk node-negative breast cancer: ten-year analysis--an intergroup studyE G Mansour, R Gray, A H Shatila, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1992
Chemotherapy versus observation in high-risk node-negative breast cancer patientsE G Mansour, L Eudey, D C Tormey, et al.
The New England Journal of Medicine|February 23, 1989
Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup studyE G Mansour, R Gray, A H Shatila, et al.
Cancer Treatment Reports|October 1, 1987
Actual versus ideal weight in the calculation of surface area: effects on dose of 11 chemotherapy agentsR S Gelman, D C Tormey, R Betensky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Concurrent radiation therapy and chemotherapy for locally unresectable squamous cell head and neck cancer: an Eastern Cooperative Oncology Group pilot studyD J Adelstein, L A Kalish, G L Adams, et al.
Blood|August 1, 1991
Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for relapsed non-Hodgkin's lymphoma: blood and bone marrow progenitor growth studies. A phase II Eastern Cooperative Oncology Group TrialH M Lazarus, J Andersen, M G Chen, et al.
American Journal of Clinical Oncology|August 1, 1995
Phase II trial of etoposide, doxorubicin, and cisplatin combination in advanced measurable gastric cancer. An Eastern Cooperative Oncology Group studyJ L Clark, O Küçük, D S Neuberg, et al.
Pageof 4